How does a risk-based workflow differ from authority acceptance and dossier validation?

A risk-based translation workflow manages the risk of failing to achieve accurate, source-faithful regulatory submission translation. It does not perform regulatory strategy, dossier validation, scientific evaluation or authority assessment. Authority acceptance, notified body acceptance, EMA acceptance and certification depend on the applicant, sponsor, marketing authorisation holder, regulatory team, medical, clinical, legal and quality reviewers, and the relevant authority or notified body. AbroadLink supports translation, terminology, review, QA and traceability across languages. Final decisions on submission adequacy, dossier acceptability and product approval remain with the client and the competent authorities.